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Introduction
Periodontitis is an inflammatory process initiated 
by plaque biofilm that leads to loss of periodontal 
attachment to the root surface and adjacent alveo-
lar bone, and which ultimately results in tooth loss.1 
Destruction of periodontal tissue in periodontal dis-
ease is caused by an inappropriate and exaggerated 
host response to certain microorganisms and their 
products.2,3 Thus, regulation of the host response, 
including immune cells and cytokines, is crucial in 
treating periodontitis.
Free radicals are any species capable of indepen-
dent existence that contain one or more unpaired 
electrons3 and are able to oxidize a variety of bio-
molecules and cell components that are vital to cell 
and tissue function. Reactive oxygen species (ROS) 
include not only free radicals but also other reactive 
species, which are not true radicals but are capable 
of radical formation in either an intra- or extracellu-
lar environment.1 Hypochlorous acid (HOCl), as one 
of the ROS, is released by neutrophils in periodon-
tal pockets, and seems to have a role in regulating 
inflammation and healing in destroyed gingival and 
periodontal tissues.2 Yet, therapeutic use of HOCl 
in periodontitis has not been well studied. Further 
studies on HOCl as an antimicrobial and health-
promoting medication may contribute to a better 
Hypochlorous acid (HOCl) has both proinflammatory and anti-inflammatory proper-
ties, and seems to play an important role in the immune system. The regulation of 
normal flora contributes to periodontal health, and HOCl seems to have the ability 
to attack Gram-negative pathogens during periodontitis. Furthermore, high concen-
trations of HOCl promote healing by regulating cytokines and growth factors, killing 
pathogens through chlorination or oxidation, and modulating inflammation through 
the effects on nuclear factor κB and activator protein-1 of monocytes. After chlo-
rination of taurine by HOCl, taurine chloramine is mostly an anti-inflammatory agent 
and enhances healing. Neither HOCl nor taurine chloramine are common in clinical 
applications owing to a lack of studies in animal and human models. Both compounds 
may be suitable as periodontal medication, as they are good antimicrobial agents, 
inflammation modulators, and healing promoters.
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prognosis for periodontitis treatment. Taurine chlo-
ramine (TauCl), a scavenging product of HOCl, has 
some of the properties of HOCl, and it seems to 
promote healing.2
Oxidative stress and the redox state
In normal physiology, the dynamic equilibrium be-
tween ROS activity and the antioxidant defense sys-
tem, which protects and repairs vital tissues, cells 
and molecular components, shifts to a defensive 
trend (Fig. 1).
Oxidant stress was defined by Sies4 as “a distur-
bance in the pro-oxidant-antioxidant balance in 
favor of the former, leading to potential damage”. 
It occurs when there are more ROS than defensive 
antioxidation, owing to either a reduction in anti-
oxidants or an increase in ROS production.1 Direct 
tissue damage results.
A low redox potential or a reducing environment 
within periodontal cells and tissues is protective 
against oxidative stress and helps maintain good 
health. However, when a periodontal pathogen is 
present, components or toxins of the pathogen stim-
ulate the production of ROS by polymorphonuclear 
neutrophils (PMNs),5 thus promoting oxidative stress 
in the periodontal sulcus or pocket.
Origins of ROS in a normal 
physiologic state
One of the origins of ROS is mitochondria. During 
cell metabolism, oxygen is consumed in glycolysis 
to generate energy, forming pyruvate within the 
mitochondria. Electrons produced from mitochon-
drial electron transport systems (respiratory chains) 
form superoxides at a constant rate as a byproduct 
of the metabolic pathway. The mitochondrial en-
zyme, manganese-dependent superoxide dismutase 
(MnSOD), scavenges superoxide radicals, converting 
them into hydrogen peroxide (H2O2). However, mi-
tochondrial antioxidant scavengers are sometimes 
unable to safely take care of all of the ROS produced. 
Mitochondria are more susceptible than nuclear DNA 
to damage by ROS6 because of their proximity to 
the ROS generated, the lack of histone proteins to 
scavenge radicals, and perhaps inefficiencies in the 
poly(adenosine diphosphate-ribose) polymerase DNA 
repair mechanism which repairs strand breaks.7
The superoxide radical anion (O2•−), the primary 
product of oxygen metabolism in the mitochon-
drial respiratory chain, is formed by the hexose-
monophosphate shunt, via the transfer of one electron 
to molecular oxygen. Another possible reason for the 
weak scavenging ability of mitochondria is that they 
lack catalase. Neutralization of H2O2 into H2O is car-
ried out by the enzyme glutathione peroxidase, with 
the requirement of a coenzyme-reduced glutathione.
Formation of ROS by PMNs
PMNs are the primary mediators of a host’s response 
to pathogenic microbes during inflammatory diseases. 
Some of the antimicrobial factors produced by PMNs 
are capable of preventing bacterial growth through 
their antibacterial properties.8 During inflammation 
especially chronic inflammation, inflammatory cells 
such as activated macrophages and PMNs release 
various ROS (H2O2, nitric oxide [NO], O2•−, and OH•) 
and HOCl.9 Some of the antimicrobial agents pro-
duced by PMNs are ROS, which provide a protective 
role for the host against inflammation.
Different kinds of mitogens, antigens (e.g., small 
peptides from bacteria), cytokines and mediators, 
like granulocyte-macrophage colony-stimulating 
factor, promote the formation of ROS by PMNs. The 
activation of the Fcγ receptor by opsonized particles, 
or toll-like receptors (e.g., TLR-4 and TLR-9) by 
bacterial DNA triggers ROS formation.10
In a zone of the PMN plasma membrane contacting 
the phagocytosed particle, O2•− is produced by acti-
vation of the hexose monophosphate shunt, in which 
molecular oxygen is catalyzed by NADPH oxidase. 
This process comprises the respiratory burst within 
PMNs. The elevated Ca2+ in PMNs, resulting from cell 
surface receptor stimulation, opens Ca2+-dependent 
K+channels in the phagolysosome (vacuole) mem-
brane. Superoxide is pumped into the vacuole by 
NADPH oxidase, depolarizing the membrane and 
generating an ionic gradient. The occurrence of 
K+influx, creating a hypertonic K+-rich alkaline en-
vironment within the vacuole, activates lysosomal 
proteases, leading to microbial destruction.11
Superoxide radical anions are reduced to H2O2 
by superoxide dismutase (SOD; 1 of 3 forms). SOD 
is localized within human periodontal ligaments 
and may play a role in defense against excessive 
superoxide release.12
Hydrogen peroxide, NO, superoxide radicals, and 
hydroxyl radicals are produced by mitochondria, 
AO
ROS
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Fig. 1 In normal physiologic conditions, the antioxidant 
(AO) defense system is always superior to the reactive 
oxygen species (ROS) system.
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leading to elevated numbers and activity of PMNs. 
In addition to those already mentioned, HOCl 
can be produced by PMNs during inflammatory 
conditions.
Effects of ROS on periodontal tissues 
and cell components
Stimulated by bacterial antigens in periodontal 
tissue, ROS produced by PMNs increase oxidative 
damage in gingival tissues, periodontal ligaments, 
and alveolar bone.13 ROS damage periodontal tis-
sues and cell components by depolymerization of 
extracellular matrix (ECM) components,14,15 lipid 
peroxidation,16 oxidation of defensive or protective 
enzymes (e.g., anti-protease),16 increased apoptosis 
in the deepest area of the sulcular pocket,17 activa-
tion of osteoclasts,18,19 induction of proinflammatory 
cytokines, and DNA damage.16
ECM components
Excessive ROS produced by PMNs destroy ECM com-
ponents and alter the metabolic reaction responsi-
ble for synthesis of ECM components. Proteoglycans 
(PGs) and glycosaminoglycans (GAGs), which are 
some of the ECM components, have been shown to 
regulate mineralization20,21 and cellular function 
by their ability to bind growth factors, such as 
transforming growth factor β.22 Thus, the overpro-
duction of ROS degrades PGs by modifying amino 
acid functional groups, leading to fragmentation 
of the core protein, while the constituent GAG un-
dergoes limited depolymerization. Sulfated GAGs 
are more resistant than non-sulfated GAGs, such 
as hyaluronan, to ROS degradation in vitro.23,24
Another important ECM component is type I 
collagen. Containing 1000 amino acids that form a 
triple helix, it resists nonspecific proteolytic attacks. 
ROS directly attack collagen, which results in frag-
mentation, and makes it more susceptible to break-
down by collagenase.24,25 Superoxide anions and 
hydroxyl radicals are able to cleave collagen into 
small peptide fragments at the proline and hydroxy-
proline residues.26 Furthermore, lipid peroxidation 
products (e.g., malondialdehyde) of ROS may inter-
act with collagen and alter fibroblast functions.27 
This phenomenon can be seen within gingival tis-
sues of patients with periodontal disease as lipid 
peroxidation increases.
Activation of osteoclasts
Although the effects of ROS on bone resorption 
are not well documented or studied, it has been 
shown that certain ROS (i.e., superoxide and H2O2) 
promote osteoclast formation.28 More substantial 
evidence supporting this theory is that osteoclasts 
produce ROS at the ruffle border/bone interface.29,30 
Chondroitin sulfate PGs from alveolar bone are par-
ticularly susceptible to damage by hydroxyl radicals 
in vitro.15 In short, ROS may worsen bone destruc-
tion in periodontal disease.
DNA damage
Mitochondrial DNA is the most susceptible mole-
cule attacked by ROS. Deletions of mitochondrial 
DNA by ROS are associated with aging and several 
chronic diseases,31 including chronic periodontitis. 
Five kilobase of mitochondrial DNA deletions was 
found in gingival tissues of patients with chronic 
adult periodontitis.32 Once the mitochondrial DNA is 
damaged, oxidative stress within a cell can be am-
plified owing to an abatement of the expression of 
proteins which are crucial for electron transport, 
resulting in cell death.
Transformation and chlorination of 
H2O2 to HOCl (Fig. 2)
When a pathogen invades periodontal tissues, PMNs 
are activated. Phagocytosis of the pathogen by PMNs 
results in assembly and activation of the respiratory 
burst NADPH oxidase in the phagolysosome mem-
brane. The oxidase reduces O2 to O2•− and releases 
O2•− into phagolysosomes. The spontaneous dismu-
tation or SOD catalysis of two O2•− radicals produces 
O2 and H2O2. Myeloperoxidase catalyzes the oxida-
tion of chloride ions by H2O2 to produce HOCl, and 
the reaction of HOCl with amines and ammonium 
ions produces toxic chloramines such as monochlo-
ramine (NH2Cl). The O2 metabolites (i.e., O2•− and 
H2O2) and products of chloride oxidation (i.e., HOCl 
and NH2Cl) contribute to the antimicrobial activity 
of phagolysosomes.
HOCl, the end-product of PMN respiratory bursts, 
results from the intracellular myeloperoxidase-
catalyzed reduction of H2O2 by chlorine during in-
flammation.2 Myeloperoxidase is a lysosomal protein 
stored in the azurophilic granules of neutrophils. 
Once HOCl is formed by PMNs, it is released extra-
cellularly.33 In addition to intracellular myeloper-
oxidase, PMNs can secrete HOCl extracellularly.33
Immunologic effects of HOCl
Antibacterial properties of HOCl
HOCl-induced oxidation and/or chlorination may 
neutralize harmful bacterial endotoxins or exotoxins, 
48 C.H. Sam, H.K. Lu
such as lipopolysaccharide (LPS) and gingipains.34 
HOCl oxidizes the crucial cysteine residue of the ac-
tive site of the gingipains, Rgp and Kgp. Both of them 
are cysteine proteases of Porphyromonas gingivalis, 
which lead to the destruction of periodontal tissues; 
thus, HOCl reduces their potentially harmful activity 
against periodontal tissues.35
Within physiologic concentration ranges, HOCl has 
immediate and highly effective microbicidal activity 
in vivo.36 Various bacterial respiratory electron trans-
porters are irreversibly oxidized by HOCl. HOCl may 
repulse some motile bacteria, especially those with 
flagella and gliding properties; however, the mech-
anism of this repulsive activity remains unclear.37 
HOCl is able to enhance the immunogen icity of anti-
gens by HOCl chlorination of the proteinaceous parts 
of the antigens; this promotes the presentation of 
these proteins to antigen-presenting cells, such as 
monocytes, macrophages, and dendritic cells.34
Although the mechanism has not yet been clearly 
elucidated, chlorination of antigens selectively pro-
motes a nonspecific immune response against Gram-
negative periodontal pathogens, and reduces the 
response induced by Gram-positive bacteria. This 
affects the antigen phagocytosis-activated produc-
tion of inflammation mediated by macrophages. 
The chlorination of Gram-positive bacteria-released 
antigens significantly affects macrophage secretory 
activities, such as decreasing NO and tumor necrosis 
factor (TNF)-α; however, phagocytosis and inter-
leukin (IL)-6 production remain unchanged.38 This 
may be critical in maintaining a normal physiologic 
state of periodontal tissues. The normal subgingi-
val flora in periodontally healthy individuals mainly 
consists of Gram-positive bacteria, while potent per-
iodontal pathogens are mostly Gram-negative bac-
teria, such as Porphyromonas gingivalis, Prevotella 
intermedia, and Actinobacillus actinomycetemcom-
itans. As the defensive ability against Gram-negative 
bacteria is greater than that against Gram-positive 
bacteria, the immune system seems capable of pro-
tecting periodontal tissues by this mechanism. If 
the amount of TNF-α production is great with normal 
Gram-positive flora, the destruction may also occur 
in periodontally healthy individuals, showing the 
importance of TNF-α in destructive periodontitis.
The antimicrobial activity of HOCl has been ex-
tensively studied. It causes respiratory loss in bacte-
rial cell membranes due to an irreversible reaction 
with sulfur- and heme-containing membrane en-
zymes and structural proteins,39 leading to cell death 
and nonviability.40
Dose-dependent inflammatory response 
modulation
HOCl seems to play a key role in this regulation of 
proteinase activity, dysregulation of which may lead 
to periodontitis through a pathway distinct from that 
of tissue inhibitors of matrix metalloproteinases, 
and appears to reduce the activity of proteolytic 
enzymes in a concentration-dependent manner.41,42
1) Induces proinflammatory and
 anti-inflammatory cytokines
 • Regulates NF-κB
 • Regulates AP-1
2) Anti-bacterial property
3) Promotes healing and repair
 • Neutralization of
  proinflammatory cytokines
  and chemokines
1) Induces proinflammatory and anti-
 inflammatory cytokines
 • Regulates NF-κB
 • Regulates AP-1
 • Increase of vascular permeability
2) Anti-bacterial property
3) Promotes healing and repair
 • Regulates TGF-β
 • α2-Macroglobulin oxidation
 • Neutralization of proinflammatory
  cytokines and chemokines
Pathogen
Superoxide
dismutase
Leukocyte
cell membrane
Leukocyte Leukocyte
cell membrane
HOCl TauCl
Cl−
H2O2
O2
−
Myeloperoxidase
Phagolysosome
Taurine
Fig. 2 Transformation and chlorination of hydrogen peroxide (H2O2) to hypochlorous acid (HOCl), and the reaction of 
HOCl with taurine. The gray boxes summarize the function of HOCl and taurine chloramine (TauCl).
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Low concentrations of HOCl may be destructive to 
periodontal tissue. A low dose of HOCl can activate 
the proforms of matrix metalloproteinases (MMPs), 
collagenase-2, and gelatinase B via thiol group oxi-
dation of their cysteine moiety, while higher con-
centrations of HOCl inhibit MMP-7 activation through 
an oxidative modification of adjacent tryptophan and 
glycine residues in the catalytic domain.41 Similarly, 
HOCl inhibits collagenase activities, when the HOCl/
collagenase ratio exceeds 40 (which indicates a high 
concentration of HOCl). HOCl may also inactivate 
gelatinases when the HOCl/gelatinase ratio exceeds 
30, while it does not seem to inhibit them when the 
ratio is < 30.43,44
Thus, HOCl possesses both pro- and anti-
inflammatory properties depending on the dose. 
This may be a very important mechanism modulat-
ing the inflammatory response within periodontal 
tissues. HOCl is capable of mediating the generation 
of histamine N-chloramines, and thus may modulate 
histamine activity, tissue distribution, and metab-
olism within sites of inflammation.45 Chemotactic 
mediators enhance leukocyte adherence to activated 
endothelium and in situ diapedesis.
Furthermore, HOCl neutralizes various proinflam-
matory cytokines and chemokines (chemotactic 
factors, leukotrienes, TNF-α, IL-1β, IL-2, and IL-6), 
regulates metalloproteinases, and releases activated 
growth factors. These reactions may be due to 
either a direct oxidation of crucial thiol or thioether 
residue(s) of the molecules or an indirect modula-
tory effect on the capacity of α2-macroglobulins to 
bind them.
α2-Macroglobulins are plasma molecules that bind 
to and neutralize proteases, cytokines, and growth 
factors. In plasma in a normal physiologic state, 
α2-macroglobulin’s binding affinity is greater to-
ward growth factors (e.g., TGF-β, basic fibroblast 
growth factor [also called FGF-2], β-nerve growth 
factor [β-NGF], and platelet-derived growth factor 
[PDGF], with dissociation constant (Kd) values in a na-
nomolar range) than to cytokines (e.g., TNF-α, IL-1β, 
IL-2, IL-6, IL-8, with Kd values in a micromolar range), 
which leads to the activities of cytokines being more 
predominant than those of growth factors. Conse-
quently, 85−90% of TGF-β and PDGF molecules are 
inactivated by being bound to α2-macroglobulins. 
When α2-macroglobulin is oxidized by HOCl, it tends 
to undergo repair and fibrosis, owing to a decrease 
in protease binding, an important increase in α2-
macroglobulin affinity for destructive or inflam-
mation-induced factors (TNF-α, IL-2, and IL-6), 
and a greater decrease in affinity to growth fac-
tors (β-NGF, PDGF-BB, TGF-β1, and TGF-β2). In ad-
dition, after being oxidized by HOCl, the oxidized 
α2-macroglobulin−methylamine complex leads to a 
decrease in the binding of various growth factors, 
resulting in increases in free growth factors, with 
no modification of its affinity to inflammatory 
cytokines.46
However, HOCl may exert a deleterious stimula-
tion of inflammatory processes. As mentioned above, 
low concentrations of HOCl may activate the pro-
forms of MMPs, gelatinase B, and collagenases. HOCl 
may also inhibit α2-macroglobulin-related neutral-
ization of cell proteases, whereas HOCl inactivates 
the α1-proteinase inhibitor.46,47 HOCl may also in-
terfere with the C5 component of the complement 
cascade which, upon activation, generates two 
fragments: the C5b fragment with antibacterial 
membrane-lytic activity, and the C5a fragment with 
PMN chemotactic properties. HOCl-induced oxi-
dation of methionine residues in the C5 fragment 
generates structural changes that result in its acti-
vation.48 HOCl promotes macrophage adherence to 
the endothelium and enhances endothelial perme-
ability.49 HOCl promotes an innate immune response 
against Gram-negative bacteria (unlike Gram-
positive species) via chlorination of antigens.38
In conclusion, unlike natural TNF-α or TNF-β, 
HOCl has a double-edged effect in periodontitis. 
Although the effects of HOCl in periodontitis are 
not well documented, HOCl seems to play a very 
important role in modulating the progress of peri-
odontitis and may help in repairing its damage. With 
further studies and evidence, HOCl may become a 
drug used in surgery or postsurgical medication.
Enhanced cell proliferation and 
extracellular component 
production by HOCl
The interruption of tissue destruction, which pro-
motes healing, is brought about by direct neutrali-
zation and cellular inhibition of proinflammatory 
mediators. HOCl also induces the production of 
cellular growth factors, such as insulin-like growth 
factor, epidermal growth factor, keratinocyte growth 
factor (also called FGF-7), FGF-1, FGF-2, TGF-β, 
PDGF, vascular endothelium growth factor, connec-
tive tissue growth factor, and/or cementum-derived 
growth factor.50 These molecules also promote peri-
odontal tissue regeneration. Signal transduction 
enzymes are involved in the synthesis of some of 
the above molecules.
Furthermore, HOCl can activate the transforming 
growth factor TGF-β, a reparative mediator which 
promotes tissue repair and fibrosis. Native TGF-β 
consists of two peptides: an N-terminal latency-
associated peptide and a C-terminal mature TGF-β. 
HOCl-induced latency-associated peptide oxidation 
may facilitate access to the active site of the ma-
ture TGF-β molecule, resulting in its activation.
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HOCl may also affect the signal transduction 
pathway in inflammatory cytokine formation. The 
nuclear factor κB and activator protein (AP)-1 are 
redox-sensitive transcription factors, the control of 
which has been proposed as a potentially important 
host-modulation strategy in periodontitis.51 NF-κB 
and AP-1 are stimulated by a specific mitogen-
activated protein (MAP) kinase pathway, which con-
sists of a cascade of transduction signals activated 
by a membrane receptor-linked protein tyrosine 
kinase. In short, their activation and phosphoryla-
tion in periodontal tissues cause periodontitis.
NF-κB is an important signal transduction pro-
tein responsible for the genetic transcription of many 
inflammatory mediators, including those regulat-
ing inflammation, acquired immunity, cell-to-cell 
interactions, cell apoptosis, and proliferation (e.g., 
IL-1α, IL-1β, IL-2, IL-6, TNF-α, NO, prostaglandin 
E2, TGF-β, and adhesion molecules), as well as in-
hibitors of apoptosis proteins. Inactive NF-κB forms 
a dimer with an IκB inhibitory protein in the cyto-
plasm, which masks its nuclear location signal site 
and latently stabilizes NF-κB. NF-κB is activated 
by specific MAP kinases, IκB kinases (IKKs). This in-
ducible serine phosphorylation leads to a polyubi-
quitination of adjacent lysines in the IκB inhibitory 
protein, which is a signal of degradation in the 26S 
proteasome pathway. This releases and activates 
NF-κB, which is translocated to the nucleus and 
binds to DNA for the transcription of inflammatory 
proteins. Activation of NF-κB by receptor-activated 
nuclear factor-κB ligand in monocytes may promote 
bone resorption through cytokine production. In 
short, NF-κB is a major molecule promoting inflam-
mation in periodontitis.
AP-1 is a two-gene-dependent transcription fac-
tor (Jun and Fos), and is capable of producing some 
cytokines (e.g., IL-8) and MMPs involved in perio-
dontitis. The monomers (c-Jun, c-Fos, v-Jun, v-Fos, 
Fos, Fra-1, Fra-2, Jun-D, Jun-B, and ATF) can gen-
erate a homodimeric complex (Jun/Jun) or a het-
erodimeric complex (Jun/Fos). This transcription 
factor family is critical to the early genetic regula-
tion of immune responses. AP-1 is activated by an-
other specific MAP kinase, c-Jun N-terminal kinase 
(JNK). Similar to IKK, JNK phosphorylates c-Jun, fol-
lowing TNF-α-receptor stimulation, thereby inducing 
AP-1 activation.
All of the mediators and proteins mentioned 
above are involved in periodontal diseases, and their 
physiologic inhibition seems to be crucial to perio-
dontal tissue turnover, and to triggering the pro-
cesses of regeneration.52 In contrast to H2O2, HOCl 
does not significantly activate JNK, except at a le-
thal dose (50 μM), thus preventing the tissue destruc-
tion caused by MMPs and IL-8. The extremely low 
doses (20−50 μM) of HOCl required for MAP kinase 
activation, compared with H2O2 (400−1000 μM), may 
be due to the high reactivity of HOCl with thiol groups 
and not to physiologic enzymatic degradation.53
A toxic concentration of HOCl oxidizes and causes 
irreversible loss of intracellular protein thiol groups, 
including glutathione, glutaredoxin and thioredoxin, 
resulting in their cross-linking and aggregation.54 
Low doses of HOCl oxidize preferentially accessi-
ble thiol residues of cysteine amino acids of vital 
cellular antioxidants, such as reduced glutathione, 
thioredoxin and glutaredoxin.
Thioredoxin expression modulates NF-κB activity 
at three levels. In the nucleus, it helps NF-κB bind 
to DNA.55 In the cytosol, it activates NF-κB at a down-
stream level of NF-κB-inducing kinase;56 while near 
cell membranes, it inhibits NF-κB-mediated cytokine 
production at a level upstream of NF-κB-inducing 
kinase and at a level downstream of TNF receptor-
associated factor protein.57 HOCl may oxidize cyto-
plasmic antioxidants close to the cell membrane, 
and thioredoxin may thus be unable to inhibit NF-κB-
mediated cytokine production in this case. There-
fore, HOCl here increases inflammatory mediator 
release.
In contrast to thioredoxin, glutaredoxin expres-
sion increases NF-κB activation and, like thioredoxin, 
increases AP-1 activation. HOCl oxidation in these 
cases seems to be anti-inflammatory.
Nonspecific oxidants, like H2O2 and HOCl, may 
modulate IκB kinase activities, which then induces 
phosphorylation of the tyrosine residue 42 instead 
of the serine residues 32/36 of IκB-α, triggering the 
dissociation of IκB-α from the NF-κB dimer. Interest-
ingly, IκB-α dissociates without degradation by the 
26S proteasome mentioned above.58 In conclusion, 
HOCl may indirectly regulate these transcription 
factors and inflammation.
Thus, although HOCl has the ability to inhibit 
redox-sensitive transcription factors, similarly to 
TauCl, antioxidant-mediated HOCl neutralization 
prevents this activity in vivo. In fact, moderate HOCl-
induced depletion of antioxidants may favor HOCl-
mediated nonspecific activation of protein tyrosine 
kinases, i.e., MAP kinases, which leads to nonspe-
cific proinflammatory gene transcription. Therefore, 
with the mechanism affecting α2-macroglobulins, 
nontoxic HOCl concentrations induce cell prolifer-
ation and stimulate ECM component production in 
human fibroblasts.59
Influence of TauCl, which scavenges 
production of HOCl, in periodontal 
disease
TauCl, a product of the neutrophil myeloperoxidase-
halide system, formed by a reaction of taurine with 
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HOCl, is known to be a long-lived antimicrobial and 
anti-inflammatory oxidant.60 As it can be formed 
by HOCl, it reveals some of the same properties. 
Nevertheless, it has more potent anti-inflammatory 
effects.
TauCl exerts a direct concentration-dependent 
inactivation of type VII collagenases,43,44 inacti-
vates α1-proteinase inhibitors46,47 like HOCl, re-
duces the HOCl-mediated increase in vascular 
permeability,49 significantly inhibits the in vitro 
cell production of various inflammatory mediators 
and ROS (e.g., IL-1β, IL-6, and IL-8) in LPS-stimulated 
human adherent monocytes, inhibits lymphocyte 
proliferation,61 interferes with transduction signals 
which generate MMP-9 expression in LPS-stimulated 
murine peritoneal macrophages,62 inactivates NF-κB 
by reducing the translocation of NF-κB and its DNA-
binding activities, inhibits the production of MCP-1, 
MIP-2, IL-1β, IL-2, IL-6, IL-8, TNF-α, NO, and pros-
taglandin E2 due to the involvement of the NF-κB 
and AP-1 transcriptional pathways,34,63 inhibits the 
NF-κB-related transcription of inducible nitric oxide 
synthase and TNF-α genes in a rat model of broncho-
alveolar macrophages,64 and inducible nitric oxide 
synthase, cyclooxygenase-2, TNF-α, MCP-1 and MIP-2 
genes in rat cortical astrocytes,63 and inhibits cy-
clooxygenase-2 gene NF-κB post-transcriptional 
events which are more accessible than transcription, 
implying that the inhibition is mainly at the post-
transcriptional level.65 Similarly, TauCl essentially 
suppresses the translation of TNF-α mRNA61 and 
induces inhibition of IKK activity by maintaining un-
phosphorylated cytoplasmic IκB-α. TauCl reduces 
IKK activation at a downstream rather than an up-
stream level in the kinase cascade. Instead of ser-
ine 32/36 phosphorylation, TauCl induces oxidation 
of IκB-α methionine 45, yielding a sulfoxide residue. 
This oxidation is likely to induce a spatial structural 
change that masks serine 32/36, preventing phos-
phorylation, or avoids phosphorylated IκB-α recog-
nition by F-box proteins and subsequent lysine 21/22 
ubiquitination.66 Consequently, it inhibits the acti-
vation of NF-κB and degradation of IκB-α. The above 
information is summarized in Table 1.
Therefore, TauCl has the ability to inhibit the 
production of the principal inflammatory mediators 
involved in the pathogenesis of periodontitis. These 
inhibitions may involve activities at the level of gene 
transcription, at the post-transcriptional stage, and/
or at mRNA translation. Consequently, TauCl not only 
protects tissues against excess HOCl (an antioxidant 
effect), but also possesses better anti-inflammatory 
and healing promotion properties.
The successful wound healing performance of 
HOCl was proven by Selkon et al.,67 who evaluated 
the effect of HOCl in treating chronic venous leg 
ulcers. They determined that using HOCl washes as 
an adjunctive therapy for recalcitrant venous leg 
ulcers appreciably increased healing and rapidly 
relieved pain. HOCl washes were given over 12 weeks 
to patients who failed to achieve a 44% ulcer reduc-
tion after 3 weeks of standard treatment. Encouraging 
results were shown after 3 weeks in which 45% of 
20 ulcers had healed and a further 25% were reduced 
by over 60% in size.
However, adversely, HOCl did not promote wound 
healing compared with electrolyzed water in another 
study.68 The author also quoted from the study of 
Kozol et al. that sodium hypochlorite (NaOCl) had 
toxic effects on wound healing (e.g., on neutrophils, 
fibroblasts, and endothelial cells even at dilute con-
centrations of 0.0005 − 0.025%).69 Wounds created 
on mouse ears and treated with 0.25% NaOCl showed 
delayed epithelialization and neovascularization.70 
The materials used in those experiments were not 
pure acidic HOCl, but alkaline NaOCl or HOCl in a 
saline solution. Thus, one cannot conclude that HOCl 
is detrimental to healing based on their conclusions.
Stabilized, healing-promoting HOCl should be 
kept at a pH of 3.5 − 5 in order to maintain its de-
sired activity.71 HOCl underwent antibacterial and 
wound healing tests, and it was found that the min-
imal bactericidal concentration of HOCl for most 
bacteria used in those experiments was < 3 μg/mL 
at room temperature for 60 minutes, except for 
Aspergillus niger, which required 86.6 μg/mL. The 
time required for bacteria to be killed was the least 
(within 1 minute), and it had the greatest relative 
therapeutic index when OCl− was compared with 
H2O2. In the wound healing test, healing was more 
obvious after the use of HOCl than saline, and atrau-
matic wiping with HOCl between dressing applica-
tions seemed to favor healing. Although in that 
research, specific periodontal pathogens were not 
included; it still indicated the importance of HOCl 
in wound healing and the antibacterial properties 
of HOCl.
Conclusion
Excessive ROS seem to be harmful to human tissues, 
while HOCl is able to modulate the inflammatory 
response, often in a concentration-dependent man-
ner, and may have both proinflammatory and anti-
inflammatory characteristics. The anti-inflammatory 
effects would appear to predominate, but the out-
comes of these multiple effects in vivo require fur-
ther exploration. TauCl, however, possesses mostly 
anti-inflammatory properties, and may promote 
healing and alleviate inflammation.
Based on the above viewpoints, the Periodontal 
Department of Taipei Medical University Hospital 
began using an ultrasonic spray of HOCl (HSP-600SME; 
52 C.H. Sam, H.K. Lu
Biotech Corp., Taiwan) for constant sterilization 
and infection control of clinical cubicles and wound 
irrigation during periodontal surgery in 2007. Appli-
cation of HOCl through an ultrasonic delivery sys-
tem may prove to be a good modality for preventing 
infections in hospitals.
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